223. SERDs, SERMs, CERANs, and PROTACs
In episode 223, Melanie Sisk joins Breast Cancer Conversations to clarify emerging endocrine therapies such as SERMs, SERDs, CERANs, and PROTACs. The discussion focuses on how these treatments, including tamoxifen and Fluvestrant, work by interacting with estrogen receptors to…